Hepatitis B Vaccine Market Size, Share & Industry Analysis, By Type (Single Antigen and Combination), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI107098

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Hepatitis B, By Key Countries 2024/2025
2. Pipeline Analysis, Key Players
3. Key Industry Developments, Mergers, Acquisitions, New Product Launches, Etc.
4. Impact of COVID-19 on the Market
Global Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Type
  2. Canada
    1. By Type
Europe Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Germany
    1. By Type
  2. France
    1. By Type
  3. U.K
    1. By Type
  4. Spain
    1. By Type
  5. Italy
    1. By Type
  6. Rest of Europe
    1. By Type
Asia Pacific Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
    1. By Type
  2. India
    1. By Type
  3. Southeast Asia
    1. By Type
  4. Japan
    1. By Type
  5. Australia
    1. By Type
  6. Rest of Asia Pacific
    1. By Type
Rest of the World Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. DYNAVAX TECHNOLOGIES
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. VBI Vaccines Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Sanofi
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Merck & Co., Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Beijing Minhai Biological Technology Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Gilead Sciences, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Beijing Tiantan Biological Products Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Amy Vaccine Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Biokangtai
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Hepatitis B, By Key Countries 2024/2025
2. Pipeline Analysis, Key Players
3. Key Industry Developments, Mergers, Acquisitions, New Product Launches, Etc.
4. Impact of COVID-19 on the Market
Global Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Type
  2. Canada
    1. By Type
Europe Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Germany
    1. By Type
  2. France
    1. By Type
  3. U.K
    1. By Type
  4. Spain
    1. By Type
  5. Italy
    1. By Type
  6. Rest of Europe
    1. By Type
Asia Pacific Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
    1. By Type
  2. India
    1. By Type
  3. Southeast Asia
    1. By Type
  4. Japan
    1. By Type
  5. Australia
    1. By Type
  6. Rest of Asia Pacific
    1. By Type
Rest of the World Hepatitis B Vaccine Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Single Antigen
  2. Combination
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals & Clinics
  2. Government Suppliers
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. DYNAVAX TECHNOLOGIES
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. VBI Vaccines Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Sanofi
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Merck & Co., Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Beijing Minhai Biological Technology Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Gilead Sciences, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Beijing Tiantan Biological Products Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Amy Vaccine Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Biokangtai
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Hepatitis B Vaccine Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 02: Global Hepatitis B Vaccine Market Value Share (%), By Type, 2025 & 2034

Figure 03: Global Hepatitis B Vaccine Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 04: Global Hepatitis B Vaccine Market Value Share (%), By Region, 2025 & 2034

Figure 05: North America Hepatitis B Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 06: North America Hepatitis B Vaccine Market Value Share (%), by Type, 2025

Figure 07: North America Hepatitis B Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 08: North America Hepatitis B Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 09: North America Hepatitis B Vaccine Market Value (USD billion), by Country, 2025 & 2034

Figure 10: North America Hepatitis B Vaccine Market Value Share (%), by Country, 2025

Figure 11: Europe Hepatitis B Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 12: Europe Hepatitis B Vaccine Market Value Share (%), by Type, 2025

Figure 13: Europe Hepatitis B Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: Europe Hepatitis B Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 15: Europe Hepatitis B Vaccine Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 16: Europe Hepatitis B Vaccine Market Value Share (%), by Country/Sub-region, 2025

Figure 17: Asia Pacific Hepatitis B Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 18: Asia Pacific Hepatitis B Vaccine Market Value Share (%), by Type, 2025

Figure 19: Asia Pacific Hepatitis B Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 20: Asia Pacific Hepatitis B Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 21: Asia Pacific Hepatitis B Vaccine Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 22: Asia Pacific Hepatitis B Vaccine Market Value Share (%), by Country/Sub-region, 2025

Figure 23: Rest of the World Hepatitis B Vaccine Market Value (USD billion), by Type, 2025 & 2034

Figure 24: Rest of the World Hepatitis B Vaccine Market Value Share (%), by Type, 2025

Figure 25: Rest of the World Hepatitis B Vaccine Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 26: Rest of the World Hepatitis B Vaccine Market Value Share (%), by Distribution Channel, 2025

Figure 27: Global Hepatitis B Vaccines Market Share Analysis (%), By Company, 2025

List of Tables

Table 01: Global Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 02: Global Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 03: Global Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 04: North America Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 05: North America Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 06: North America Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 07: U.S. Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 08: Canada Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 09: Europe Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 10: Europe Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 11: Europe Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

Table 12: Germany Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 13: France Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 14: U.K. Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 15: Spain Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 16: Italy Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 17: Rest of Europe Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 18: Asia Pacific Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 19: Asia Pacific Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 20: Asia Pacific Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

Table 21: China Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 22: India Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 23: Southeast Asia Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 24: Japan Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 25: Australia Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 26: Rest of Asia Pacific Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 27: Rest of the World Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 28: Rest of the World Hepatitis B Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 126

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com